Releases - Biotage

View:

2005

 

Found press releases

 

Interim report January – September 2005

10/19/2005 2:30 AM EST
• Sales in the third quarter 2005 amounted to 126.6 MSEK (84.5) and sales
in the period January – September 2005 to 292.0 MSEK (260.4).
• The operating result for the third quarter amounted to –20.6 MSEK (-26.2) and the operating result for the nine month period to -58.3 MSEK (-62.3). Adjusted for non-recurring items the operating result for the third quarter amounted to -5.4 MSEK and the operating result for the...

Biotage AB Acquires Separtis Holding AG for 1.4M Euros (13M SEK) and Completes E...

10/6/2005 3:00 AM EST
Biotage has acquired Separtis Holding AG, the Swiss, German and Austrian distributor for many Biotage products, formerly the Argonaut Technologies consumable product range. Under the terms of the agreement Biotage will retain all current Separtis employees, assume the leased facilities in Grenzach-Wyhlen, and own all assets of Separtis, which is based in Grellingen, Switzerland with operating legal entities within...

Biotage resolves upon a rights issue

9/13/2005 2:34 AM EST
On September 12, 2005 the board of Biotage AB resolved, based on the authorization to the board by the extraordinary shareholders’ meeting held on August 30, 2005, to increase the company’s share capital by not more than SEK 8,044,212 through an issue of not more than 8,044,212 new ordinary shares, or such higher amount or such higher number of shares that may come from exercise of warrants entitling to subscription...

Biotage issues 10 million new shares and intends to execute a rights issue

9/8/2005 3:34 AM EST
On September 7, 2005 the board of Biotage AB decided to increase the company’s share capital by means of a new issue of 10 million shares. The shares are subscribed by Carnegie Investment Bank for resale to a limited number of institutional investors in Sweden and abroad. The decision was based on the authorization to the board by the extraordinary shareholders’ meeting held on August 30, 2005.

By the new issue,...

Biotage receives an order for multiple cGMP HPLC systems

9/5/2005 11:18 AM EST
One of the world’s leading peptide suppliers has purchased multiple Kiloprep® 2000 HPLC systems, cartridge modules and cartridges totaling approximately 8.5 MSEK (1.1 MUSD). These instruments and consumables will be used to purify 100’s of kilograms of a new peptide therapeutic.

“This recent investment is the result of a 15-year relationship based upon Biotage’s expertise in prepacked cartridge technology and...

Resolutions at the Extraordinary General Meeting in Biotage AB on August 30, 200...

8/30/2005 1:56 PM EST
At the Extraordinary General Meeting held in Biotage AB on August 30, 2005, the General Meeting resolved, in accordance with the proposal by the Board of Directors, to authorise the Board of Directors for the period up to the next annual shareholders’ meeting to adopt decisions, on one or several occasions and with or without preferential rights for the shareholders, to issue a total maximum of 20,000,000 new...

Biotage has received its largest order to date

8/11/2005 7:00 AM EST
Biotage has received the company’s largest single order to date. It includes 31 instruments and totals approx. 15 MSEK. The customer is one of the world’s major pharmaceutical companies. The instruments, which originate from the recently acquired company Argonaut, will be used by chemists to enhance the processes used in the development of pharmaceuticals.

“It’s encouraging that we have received an order of this...

Extraordinary General Meeting

8/5/2005 9:15 AM EST
The Board of Directors of Biotage has resolved to convene an extraordinary general meeting in order to adopt a resolution to authorize the Board of Directors to issue a total maximum of 20,000,000 new shares, or convertible debentures corresponding to such number of shares, with or without deviation from the shareholders preferential right, against payment in cash, through an issue in kind or through set-off,...

Interim report January – June 2005

7/28/2005 7:19 AM EST
- Sales in the second quarter 2005 amounted to 93.5 MSEK (88.9) and sales
in the period January – June 2005 to 165.4 MSEK (175.9).
- The operating result for the second quarter amounted to –15.5 MSEK (-13.4) and the operating result for the period January – June to -37.7 MSEK (-36.1).
- The net result for the second quarter was positive, amounting to 0.8 MSEK (-11.3).
- Earnings per share for the second quarter...

Biotage issues further 3.4 million new shares

7/1/2005 2:30 AM EST
On June 30, 2005, the board of Biotage AB decided to increase the company’s share capital by means of a new issue of 3.4 million shares. The shares are subscribed by Carnegie Investment Bank for resale to a limited number of institutional investors in Sweden and abroad. The decision is based on the authorization to the board by the annual general meeting held on April 27, 2005. Through the present new issue and the...

Biotage

Biotage accelerates the drug discovery and development process and increases the knowledge of the importance of the genetic make-up by providing complete solutions for medicinal chemistry research and applied genetic ana...

View more


  CONTACT